SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-037831
Filing Date
2019-02-13
Accepted
2019-02-13 15:28:33
Documents
2
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND IV GP MANAGER, LTD.OMEGA FUND IV GP, L.P.OMEGA FUND V GP MANAGER LTD.OMEGA FUND V GP, L.P.OMEGA FUND V, L.P.OTELLO STAMPACCHIARICHARD LIM

Document Format Files

Seq Description Document Type Size
1 SC 13G d672737dsc13g.htm SC 13G 217997
2 EX-99.1 d672737dex991.htm EX-99.1 12980
  Complete submission text file 0001193125-19-037831.txt   232836
Mailing Address 185 DARTMOUTH STREET BOSTON MA 02116
Business Address 185 DARTMOUTH STREET BOSTON MA 02116 617-502-6538
Omega Fund IV, L.P. (Filed by) CIK: 0001528382 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Subject) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90547 | Film No.: 19596739
SIC: 2836 Biological Products, (No Diagnostic Substances)